Mitchell Mutz
Board director at Bonum Therapeutics · Executive at Amplyx Pharmaceuticals
San Francisco Bay Area
Find your path to Mitchell
489 people in our graph share verified history with Mitchell — schools, employers, funds. One of them is your warm intro.
Oren EtzioniunlockedMitchell: together at Harvard University (1985–1986)
×3Mitchell: together at Princeton University
Mitchell: together at Samsara Biocapital
Mitchell: together at Harvard University
About
Mitchell Mutz, PhD, is Senior Principal at Samsara BioCapital, where he focuses on therapeutics investments. He previously served as Entrepreneur Partner at Vivo Capital and Senior Investment Director at the Roche Venture Fund, and his sourced or led deals include Pandion Therapeutics, Ajax Therapeutics, Enliven Therapeutics, and Scale Biosciences. Earlier in his career, he co-founded Amplyx Pharmaceuticals, serving as president and chief scientific officer, and was on the founding team of Labcyte; he holds a PhD in chemistry from the University of Rochester and is named on 38 issued patents.
Board director at Bonum Therapeutics
Intro paths
→
In turn, Mitchell can intro founders to Bonum Therapeutics's investors below.
Bonum Therapeutics's investors · 6
Co-founders at Bonum Therapeutics
JM
John MulliganExecutive Officer, Director, Promoter
Executive at Amplyx Pharmaceuticals
Intro paths
→
In turn, Mitchell can intro founders to Amplyx Pharmaceuticals's investors below.
Amplyx Pharmaceuticals's investors · 5
Experience
- Samsara BioCapitalSenior Principalcurrent2025 — presentPalo Alto, California, United States
- Vellum BiotechnologyChief Executive Officercurrent2022 — present
- Vivo CapitalEntrepreneur Partner2021 — 2025Palo Alto, California, United States
- Codon CapitalPartner2020 — 2021San Francisco Bay Area
- Roche Venture FundSenior Investment Director2019 — 2020South San Francisco, CA
- Roche Venture FundInvestment Director2017 — 2019San Francisco Bay Area
- Codon CapitalVenture Partner2016 — 2017San Francisco Bay Area
- Amplyx PharmaceuticalsCo-founder, President, and Chief Scientific Officer2007 — 2016
- LabcyteFounding Team and Principal Scientist2000 — 2007
- American Chemical Societymember1985 — 2007
- SciosScientist1999 — 2000
- Palo Alto Institute of Molecular MedicineScientist1997 — 1999
- State Theatre OrchestraHornist1990 — 1991
- National Centre for Orchestral StudiesStudent1986 — 1987
Frequently asked questions
- Who is Mitchell Mutz?
- Mitchell Mutz, PhD, is Senior Principal at Samsara BioCapital, where he focuses on therapeutics investments. He previously served as Entrepreneur Partner at Vivo Capital and Senior Investment Director at the Roche Venture Fund, and his sourced or led deals include Pandion Therapeutics, Ajax Therapeutics, Enliven Therapeutics, and Scale Biosciences. Earlier in his career, he co-founded Amplyx Pharmaceuticals, serving as president and chief scientific officer, and was on the founding team of Labcyte; he holds a PhD in chemistry from the University of Rochester and is named on 38 issued patents.
- Where does Mitchell Mutz work?
- Mitchell Mutz is Board director at Bonum Therapeutics and Executive at Amplyx Pharmaceuticals.
- Where did Mitchell Mutz go to school?
- Mitchell Mutz studied at Princeton University; University of Rochester (PhD, Chemistry); Goldsmiths, University of London (MA, Music Performance).
Same school
Also attended Princeton University1,000
Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures
+ 994 more
Also attended Goldsmiths, University of London32
Zimri RodriguezVenture Programs Coordinator at Keyhorse CapitalBrittany CrockettContent Strategy & Communications at Slauson & Co.Jim KeyesSenior Advisor at C5 CapitalMaximilian ConradInvestment Associate at DvH VenturesDanila De StefanoInvestor at Enzo VenturesSofija BogevaGrowth Track Manager at Rockstart
+ 26 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Oberlin College46
Tiffany FooInvestor at Initialized CapitalFred CummingsFounder, President, Portfolio Manager at BTECH CONSORTIUMYaoyao ChenAssociate Analyst at BTECH CONSORTIUMNicholas FergusonAssociate at BTECH CONSORTIUMMira InbarPartner at ArcTern VenturesAllison PazInvestor at Reign Ventures
+ 40 more
Shared employers
Also worked at Vivo Capital21
Aaron RoystonManaging Partner at venBio PartnersMichael ChangManaging Partner at Vivo CapitalShan FuManaging Partner at Vivo CapitalDaisy XuManaging Director at Vivo CapitalJack NielsenManaging Partner at Vivo CapitalKevin DaiManaging Director at Vivo Capital
+ 15 more
Also worked at Codon Capital1
Also worked at Roche Venture Fund229
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 223 more
